Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Payables (2018 - 2025)

Historic Payables for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $2.4 million.

  • Bio's Payables fell 427.59% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 427.59%. This contributed to the annual value of $2.1 million for FY2024, which is 2879.42% up from last year.
  • Per Bio's latest filing, its Payables stood at $2.4 million for Q3 2025, which was down 427.59% from $1.7 million recorded in Q2 2025.
  • Bio's 5-year Payables high stood at $5.7 million for Q1 2022, and its period low was $965000.0 during Q1 2021.
  • Moreover, its 5-year median value for Payables was $2.3 million (2021), whereas its average is $2.7 million.
  • Examining YoY changes over the last 5 years, Bio's Payables showed a top increase of 49098.45% in 2022 and a maximum decrease of 3645.4% in 2022.
  • Bio's Payables (Quarter) stood at $2.4 million in 2021, then plummeted by 36.45% to $1.5 million in 2022, then grew by 8.67% to $1.7 million in 2023, then increased by 28.79% to $2.1 million in 2024, then rose by 10.53% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $1.7 million for Q2 2025, and $4.0 million during Q1 2025.